Tonix Pharmaceuticals Announces CMO Retirement Effective Aug 20, 2026

What Happened

• Tonix Pharmaceuticals Holding Corp. filed a Form 8-K on July 21, 2026 reporting that on July 20, 2026 Dr. Gregory M. Sullivan informed the company he will retire from his role as Chief Medical Officer, effective August 20, 2026.
• The 8-K is reported under Item 5.02 (Departure of Directors or Certain Officers).

Key Details

• Executive: Dr. Gregory M. Sullivan, Chief Medical Officer.
• Notice date: July 20, 2026 (company filed 8-K July 21, 2026).
• Effective retirement date: August 20, 2026.
• Filing category: Item 5.02 — change in certain officers (no successor named in the 8-K).

Why It Matters

• This is a confirmed management change at the C-suite level for Tonix. Executive departures can affect oversight of clinical programs and regulatory communications, so investors typically watch for successor appointments and transition plans.
• The company’s 8-K documents the retirement but does not disclose a replacement or transitional details; investors should monitor future filings and company announcements for information about a successor or interim arrangements.